Nebulized Epoprostenol (FLOLAN) and Phenylephrine on One Lung Ventilation (OLV)
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
This is a pilot study of a new use of Epoprostenol via inhalation (Epoprostenol is approved
for intravenous use). The purpose of this study is to administered inhaled Epoprostenol and
intravenous Phenylephrine to improve arterial oxygen tension during one-lung anesthesia
either with volatile anesthesia (Sevoflurane) or with intravenous anesthesia (Propofol).